From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D002784:Cholesterol / Q000097:blood*; D003257:Consumer Product Safety; D064420:Drug-Related Side Effects and Adverse Reactions; D004864:Equipment and Supplies / Q000009:adverse effects*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D011933:Reagent Kits, Diagnostic; D013449:Sulfonamides / Q000627:therapeutic use*; D018170:Sumatriptan; D014481:United States; D014486:United States Food and Drug Administration
D007211:Indoles; D011933:Reagent Kits, Diagnostic; D013449:Sulfonamides; D018170:Sumatriptan; D002784:Cholesterol